Market revenue in 2023 | USD 137.5 million |
Market revenue in 2030 | USD 199.4 million |
Growth rate | 5.4% (CAGR from 2023 to 2030) |
Largest segment | Percutaneous thrombectomy devices |
Fastest growing segment | Catheter-directed thrombolysis (CDT) devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-directed thrombolysis (CDT) devices, Inferior vena cava filters (IVCF) |
Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Teleflex Inc, Edwards Lifesciences Corp, LeMaitre Vascular Inc, Cook Medical, DePuy Synthes, iVascular, Vascular Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clot management devices market will help companies and investors design strategic landscapes.
Percutaneous thrombectomy devices was the largest segment with a revenue share of 36.15% in 2023. Horizon Databook has segmented the Canada clot management devices market based on neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (cdt) devices, inferior vena cava filters (ivcf) covering the revenue growth of each sub-segment from 2018 to 2030.
The growing incidence of thrombosis, the rising geriatric population prone to cardiac illnesses, advancing medical technology, favorable reimbursement policies, and increasing awareness of clot management devices are some of the key reasons responsible for the clot management market growth in Canada.
In addition, regulatory approvals for products for stroke patients are expected to continue to provide lucrative market opportunities. For instance, in February 2022, Vena Medical received approval from Health Canada for its Vena Balloon Distal Access Catheter, which can be used to remove blood clots in stroke victims.
Moreover, the device is extensively used in Canadian medical centers due to its capability to remove blood clots in under 10 minutes. The prevalence of thrombosis conditions such as Deep Vein Thrombosis (DVT) and pulmonary embolism is significantly growing in the country, thereby driving the demand for effective medical devices.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada clot management devices market , including forecasts for subscribers. This country databook contains high-level insights into Canada clot management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account